Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Willman

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Immunity|October 24, 2001
Inhibition of beta 2 integrin receptor and Syk kinase signaling in monocytes by the Src family kinase FgrC M Vines, J W Potter, Y Xu, et al.
Lancet (London, England)|June 18, 1994
Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implicationsB J Kuss, R G Deeley, S P Cole, et al.
Blood|July 27, 1999
Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group StudyC P Leith, K J Kopecky, I M Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1990
Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reactionK E Noonan, C Beck, T A Holzmayer, et al.
Blood|August 15, 1997
Association of PML-RAR alpha fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: an intergroup molecular studyR E Gallagher, C L Willman, J L Slack, et al.
Leukemia|April 16, 2011
GSI-I (Z-LLNle-CHO) inhibits γ-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemiaX Meng, K Matlawska-Wasowska, F Girodon, et al.
Leukemia|June 23, 2012
Mutations in the DNMT3A exon 23 independently predict poor outcome in older patients with acute myeloid leukemia: a SWOG reportF Ostronoff, M Othus, P A Ho, et al.
Blood|November 24, 2001
Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group studyA F List, K J Kopecky, C L Willman, et al.
Leukemia|September 28, 2013
Cytogenetics and outcome of infants with acute lymphoblastic leukemia and absence of MLL rearrangementsP De Lorenzo, A V Moorman, R Pieters, et al.
Blood|December 9, 2000
Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group StudyM L Slovak, K J Kopecky, P A Cassileth, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Immunity|October 24, 2001
Inhibition of beta 2 integrin receptor and Syk kinase signaling in monocytes by the Src family kinase FgrC M Vines, J W Potter, Y Xu, et al.
Lancet (London, England)|June 18, 1994
Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implicationsB J Kuss, R G Deeley, S P Cole, et al.
Blood|July 27, 1999
Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group StudyC P Leith, K J Kopecky, I M Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1990
Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reactionK E Noonan, C Beck, T A Holzmayer, et al.
Blood|August 15, 1997
Association of PML-RAR alpha fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: an intergroup molecular studyR E Gallagher, C L Willman, J L Slack, et al.
Leukemia|April 16, 2011
GSI-I (Z-LLNle-CHO) inhibits γ-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemiaX Meng, K Matlawska-Wasowska, F Girodon, et al.
Leukemia|June 23, 2012
Mutations in the DNMT3A exon 23 independently predict poor outcome in older patients with acute myeloid leukemia: a SWOG reportF Ostronoff, M Othus, P A Ho, et al.
Blood|November 24, 2001
Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group studyA F List, K J Kopecky, C L Willman, et al.
Leukemia|September 28, 2013
Cytogenetics and outcome of infants with acute lymphoblastic leukemia and absence of MLL rearrangementsP De Lorenzo, A V Moorman, R Pieters, et al.
Blood|December 9, 2000
Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group StudyM L Slovak, K J Kopecky, P A Cassileth, et al.
Pageof 9